Rashad Rasul’s Post

Advancements in biosciences tools like immunohistochemistry calibration are rapidly evolving. For industry professionals, staying informed on these new technologies separates the rising stars from the stagnant. This compelling webinar dives into how calibration can solve major inconsistencies in testing. Early adopters who master these techniques can gain a competitive edge and speed their career trajectory. Don't get left behind - read up on this emerging tech now https://lnkd.in/gg_RmxPG . And check https://lnkd.in/gPfWftzr regularly for the hottest biotech job openings to propel your career to the next level. #biotechjobboard #biotechjobs #greatnessbio #IHCcalibration

*ATTENTION TO ALL MY FRIENDS IN THE TECH UNIVERSE* We just had 8 AMAZING opportunities open up that you really should check out. If you've been thinking about taking your tech superpowers over to science, then THIS is your opportunity to be at the epicenter of the paradigm shift in science and medicine...literally. On top of these being amazing opportunities where you can truly make your mark on an entire industry, Ryan Copping is an outstanding leader and visionary. BIOLOGY IS WHERE IT'S AT!!! Link to the 8 postings (4 Function Heads, and 4 Domain Head/Matrix Team Leader positions): https://lnkd.in/drhBkcvq [note: pls search for #gCSCatalysts and all 8 postings should display] #softwareengineering #softwaredevelopment #dataengineering #datascience #bigdata #artificialintelligence #machinelearning #weareroche

Great science doesn’t happen in isolation. It requires teams and partners across the scientific enterprise working together cross-discipline to bring it to life, and to the market. That’s why Inova has joined forces with IN-PART to become Inpart. We’ve been working hard behind the scenes since January 2022 to bring you a single entity dedicated to helping bring science to life. The union of our two platforms and companies into an integrated unit will help support the deployment of discoveries made by researchers in an academic, biotech and startup lab to the market. Already we have 16,000 scientific decision-makers - academics, R&D teams, venture firms, tech transfer offices - using our platform to connect around new research and breakthroughs. To be included in the Inpart journey, check out our new website → https://lnkd.in/eEKcGTdV and take a minute to join the network if you haven’t already (it’s free!) → https://lnkd.in/er3AnHMY #openinnovation #externalinnovation #techtransfer #researchimpact

7 weeks until the end of 2023. Some companies will double down on hiring processes. The rest will let processes linger into January. They’ll continue to wonder why they can’t secure people and their average time to hire is 90+ days. Rx Group are helping biotech companies across California, North Carolina, Massachusetts and Florida with securing key hires before the end of the year. All of these companies are committed to the processes - because if they secure the right people, they know they’ll play a huge role in accelerating certain milestones in their journey to commercialisation. Don’t stutter into next year without your full squad! #biotech #talent #qualityassurance #cmc #techops

Amidst news of layoffs and a downturn in the biotech industry due to reduced capital funding, it was encouraging to see this article about the continued growth of biotech jobs in Massachusetts. I've been through slow downs in this industry several times in the past, but life-saving technology is a safe bet for the future. This too will pass 😊 https://lnkd.in/dnZ722bq #biotechnology

If you are confused about what kind of Masters you want to choose after Bachelor’s in Biotech, this community meet up is exclusive for you. I would be counselling people 1:1 on this day! This is an invite only event. Make sure you pass on to your Biotech fellows who are graduating this year. Join this *Road to Master's Education in Biotech | Chennai Edition* to meet industry experts and understand the latest biotech trends. Regards, Team

In less than 2 weeks, BioNTX’s Tech Transfer Office Showcase Application will close!   Texas academic institutions that have technologies available for licensing, collaboration, and/or acquisition have the opportunity to pitch their best intellectual property to an audience of industry leaders and investors at BioNTX’s iC³ Life Science Summit!   Hear the contestants’ testimonials from last year’s TTOS:   “The BioNTX Tech Transfer Showcase application and mentoring process was a fantastic experience. I would highly recommend this pitch event to any Tech Transfer Office looking to increase visibility and gain commercially minded feedback on your technologies.” – Don Anderson, MBA, Ph.D. Senior Innovation Manager at Baylor University.   “The Tech Transfer Showcase is an excellent example of how BioNTX is serving Texas universities and creating a strong life science ecosystem across the State.” - Jennifer Souter, MBA, Senior Licensing Associate, Office of Research Commercialization at Texas Tech University.   “BioNTX has created a unique opportunity for academic faculty to connect with and discuss our technologies with leading industry executives and commercially focused investors and partners. The feedback and conversations are vital to ensure that our basic research efforts align with commercial interests.” – Venu Varanasi, PhD, Associate Professor, Bone Muscle Research Center, The University of Texas at Arlington.   Apply before the application closes on Monday, August 21, 2023. https://lnkd.in/dq-atskb #innovation #research #technology #healthcare #techtransfer #ttos #university #commercialization #lifesciences #biotech #texas